NexgenRX Inc. (NXG) — Cash Flow Reinvestment Rate
NexgenRX Inc. (NXG) has a Cash Flow Reinvestment Rate of 0.06x as of September 2025, reinvesting CA$55.65K (capex CA$18.07K plus investments CA$-37.58K) from operating cash flow of CA$880.82K. Explore NexgenRX Inc. capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
NexgenRX Inc. Cash Flow Reinvestment Rate (2013–2024)
Historical reinvestment intensity for NexgenRX Inc. across 8 annual periods. Also explore how large is NexgenRX Inc.'s balance sheet for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for NexgenRX Inc. (2013–2024)
Year-by-year capital reinvestment analysis for NexgenRX Inc.. For live market cap and broader valuation context, see market cap of NexgenRX Inc..
| Year | Reinvestment Rate | Total Reinvested (CAD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.43x | CA$498.33K | CA$1.15 Million | CA$317.69K | ▲ +122.8% |
| 2023 | 0.19x | CA$248.41K | CA$1.28 Million | CA$248.41K | ▼ -76.8% |
| 2022 | 0.84x | CA$895.42K | CA$1.07 Million | CA$388.81K | ▲ +114.7% |
| 2021 | 0.39x | CA$1.50 Million | CA$3.82 Million | CA$126.55K | ▼ -13.4% |
| 2020 | 0.45x | CA$1.20 Million | CA$2.65 Million | CA$120.74K | ▼ -53.1% |
| 2019 | 0.96x | CA$1.01 Million | CA$1.05 Million | CA$50.78K | ▼ -33.4% |
| 2016 | 1.45x | CA$710.00K | CA$490.96K | CA$355.00K | ▲ +2269.5% |
| 2013 | 0.06x | CA$47.24K | CA$774.08K | CA$47.24K | — |